Applied Dna Sciences (NASDAQ:BNBX) Stock Price Down 12.2% – What’s Next?

Shares of Applied Dna Sciences Inc (NASDAQ:BNBX) traded down 12.2% on Thursday . The company traded as low as $0.3710 and last traded at $0.3710. 99,644 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 266,547 shares. The stock had previously closed at $0.4226.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Applied Dna Sciences in a research note on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Applied Dna Sciences Price Performance

The business’s 50 day moving average is $0.47. The company has a market cap of $2.77 million, a P/E ratio of -0.01 and a beta of 0.52.

Applied Dna Sciences (NASDAQ:BNBX) last issued its earnings results on Friday, May 15th. The company reported ($0.68) earnings per share (EPS) for the quarter. The company had revenue of $1.02 million during the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.